Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development

BACKGROUND: COPD is a pulmonary disorder often accompanied by cardiovascular disease (CVD), and current treatment of this comorbidity is suboptimal. Systemic inflammation in COPD triggered by smoke and microbial exposure is suggested to link COPD and CVD. Mesenchymal stromal cells (MSC) possess anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Khedoe, P. Padmini S. J., de Kleijn, Stan, van Oeveren-Rietdijk, Annemarie M., Plomp, Jaap J., de Boer, Hetty C., van Pel, Melissa, Rensen, Patrick C. N., Berbée, Jimmy F. P., Hiemstra, Pieter S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598950/
https://www.ncbi.nlm.nih.gov/pubmed/28910300
http://dx.doi.org/10.1371/journal.pone.0183741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598950/
https://www.ncbi.nlm.nih.gov/pubmed/28910300
http://dx.doi.org/10.1371/journal.pone.0183741

Ejemplares similares